Skip to main content
. 2022 Aug 31;33(4):457–471. doi: 10.1007/s12022-022-09729-x

Table 4.

Comparison between data of the present systematic review and that of a previous one [11]

Present systematic review Previous systematic review [11]
Articles found 271 95
Articles included 33 10
ITN
Total cases 4940 1168
Cancer prevalence 32.4% (29.2–35.5) 34% (28–41)
TIR3A
Total cases 2626 441
Cancer prevalence 12.4% (8.8–15.9) 17% (12–22)
TIR3B
Total cases 2314 727
Cancer prevalence 44.4% (40.1–48.8) 47% (40–55)

Cancer prevalence is reported as pooled result with CI 95%